Sort
50,496 grants matching “lung cancer”
Project 3: Identifying transcriptional driver genes and targeting transcription in TSC
$492,594David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2021 · CA
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs
$492,582Joseph C Wu · Stanford University · R01 · FY2017 · HL
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs
$492,582Joseph C Wu · Stanford University · R01 · FY2016 · HL
Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs
$492,582Joseph C Wu · Stanford University · R01 · FY2014 · HL
Toward precision radiotherapy: Physiological modeling of respiratory motion based on ultra-quality 4D-MRI
$492,567G. Wilson Miller · University Of Virginia · R01 · FY2019 · CA
Tribally Engaged Approaches to Lung Screening (TEALS)
$492,561Zsolt J Nagykaldi · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2020 · CA
The Women's Health Study: Addition of New Data to Maximize its Research Impact
$492,524Julie E Buring · Brigham And Women'S Hospital · RC1 · FY2010 · HL
Interaction of histamine-releasing factor with immunoglobulins in asthma
$492,522Toshiaki Kawakami · La Jolla Institute For Immunology · R01 · FY2014 · HL
A novel preclinical model of spontaneous metastasis
$492,427Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Mechanisms of enhancer regulation in leukemia
$492,409Iannis Aifantis · New York University School Of Medicine · R01 · FY2022 · CA
Mechanisms of enhancer regulation in leukemia
$492,409Iannis Aifantis · New York University School Of Medicine · R01 · FY2023 · CA
Simultaneous dose and dose rate optimization for clinical FLASH proton radiotherapy
$492,387Hao Gao · Ut Southwestern Medical Center · R01 · FY2025 · CA
Extracellular Vesicles in Small Cell Lung Cancer Early Detection
$492,386Serge P Nana-Sinkam · Virginia Commonwealth University · U01 · FY2020 · CA
TGF-beta for Pleurodesis
$492,336Cumberland Pharmaceuticals, Inc. · R42 · FY2004 · HL
Efficacy and mechanisms of a behavioral therapy for insomnia coexisting with COPD
$492,323Mary C Kapella · University Of Illinois At Chicago · R01 · FY2015 · NR
Nanoscintillator-based X-ray sensitizers to enable efficient NSCLC treatment with X-ray irradiation
$492,320Jin Xie · University Of Georgia · R01 · FY2017 · EB
Crosstalk Between Metabolism and Inflammation in Pulmonary Hypertension
$492,243Kurt R Stenmark · University Of Colorado Denver · R01 · FY2015 · HL
Phase I/II clinical evaluation of ABTL0812, a novel PI3K/Akt/mTOR inhibitor, with a unique mechanism of action inpancreatic cancer (Protocol sent on 20th June 2019 as an amendment of the IND 137394)
$492,233Davendra Sohal · University Of Cincinnati · R01 · FY2023 · FD
Mechanisms of STING in malignant progression and therapy of CLL.
$492,142Chih-Chi Andrew Hu · Methodist Hospital Research Institute · R01 · FY2025 · CA
Mechanisms of STING in malignant progression and therapy of CLL.
$492,142Chih-Chi Andrew Hu · Methodist Hospital Research Institute · R01 · FY2023 · CA
EZH2 in cancer biology and novel inhibitors
$492,047Jun Qi · Dana-Farber Cancer Inst · R01 · FY2019 · CA
CELL AND VECTOR PRODUCTION
$492,025Helen E Heslop · Baylor College Of Medicine · P01 · FY2017 · CA
Synergistic combination of Proteolysis Targeting Chimera with a translational formulation for the treatment of intractable lung carcinoma
$492,000Ketankumar D. Patel · St. John'S University · R15 · FY2023 · CA
Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics
$491,992William R Roush · Scripps Florida · R01 · FY2016 · CA
Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics
$491,992William R Roush · Scripps Florida · R01 · FY2015 · CA